+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06749483

Study of the Gut Microbiomes Role in Sepsis and Brain Health in Intensive Care Patients Including Tissue, Fluid Samples, Brain Imaging, and Neuropsychological Tests

Led by Jena University Hospital · Updated on 2024-12-30

100

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how reducing the complexity of the gut microbiome with broad spectrum antibiotics affects patients with severe infections or sepsis. This observational study focuses on the interactions between gut bacteria and the human host, looking closely at how changes in the microbiome may relate to brain dysfunction in both the short and long term. The study also examines differences in immune cell types and activation between younger and older patients with and without sepsis. The study involves collecting stool, rectal swabs, and blood plasma samples from critically ill patients, some treated with antibiotics like piperacillintazobactam or meropenem, and others not receiving antibiotic therapy during their ICU stay. Long-term survivors of sepsis, at least six months post-critical illness, are also included. Samples are taken at five time points day 1, day 7, and day 14 during ICU treatment, plus follow-ups at 3 and 6 months. Clinical, neuropsychological, and neuroimaging data are gathered to assess brain function. Participants undergo daily delirium screenings while in the ICU and cognitive tests at hospital discharge. During follow-ups, functional MRI and neuropsychological assessments are performed. The study tracks brain dysfunction from enrollment to 180 days and records secondary outcomes like survival, ICU days, days on respirators, and days needing vasopressor support. This comprehensive approach aims to connect microbiome changes to clinical outcomes and brain health over time.

CONDITIONS

Brief Title

The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?

Research Team

J

Johannes Ehler, Priv.-Doz. Dr. med.

K

Katrin Ludewig, Dr. med.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here